Vacinas COVID-19 e outros imunobiológicos intervalos preconizados / COVID-19 vaccines and other immunobiological drugs recommended intervals
Arq. Asma, Alerg. Imunol
; 5(2): 113-114, abr.jun.2021. ilus
Article
in Portuguese
| LILACS
| ID: biblio-1398821
Responsible library:
BR2717.9
RESUMO
Com o início do programa de vacinação contra a COVID-19 no Brasil, surgiu uma série de questionamentos relacionados ao uso dos imunizantes. Neste documento, o grupo de estudo da COVID-19 da Associação Brasileira de Alergia e Imunologia (ASBAI) avalia as evidências científicas e se posiciona em relação aos intervalos preconizados entre a administração das vacinas contra o SARS-CoV-2 e dos imunobiológicos.
ABSTRACT
With the beginning of the COVID-19 vaccination program in Brazil, a series of questions related to the use of vaccines arose. In this document, the COVID-19 study group of the Brazilian Association of Allergy and Immunology (ASBAI) assesses the scientific evidence and takes a stand for the recommended intervals between the administration of SARS-CoV-2 vaccines and that of immunobiological drugs.
Full text:
Available
Collection:
International databases
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.3 End transmission of communicable diseases
Health problem:
Target 3.3: End transmission of communicable diseases
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
/
Pneumonia
Database:
LILACS
Main subject:
COVID-19 Vaccines
/
COVID-19
/
ChAdOx1 nCoV-19
Type of study:
Practice guideline
Limits:
Humans
Language:
Portuguese
Journal:
Arq. Asma, Alerg. Imunol
Journal subject:
Biologia
/
Cincia
Year:
2021
Document type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Associação Brasileira de Alergia e Imunologia/BR
/
UNIRIO/BR
/
Universidade Federal de Pernambuco/BR